4-Iodo-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole, 97%, 100mg

6-(Acetylamino)-4-methylpyridine-3-boronic acid, 98%, 1g

2-Nitrobenzyl cyclohexylcarbamate, 98%, 250mg

3-Amino-N,N-dimethylbenzamide, 95.0%, 1g

3-Chloro-2-hydroxypyridine-5-carboxylic acid, 98.0%, 100g

Plan phase PLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

4-(4-Pentyloxybenzoyl)isoquinoline, 97.0%, 1g

Phenyl n-propyl sulfide, 99.0%, 1g

2-Isobutyrylcyclohexanone, 96.0%, 1g

Vinyltrisopropoxysilane, 98%, 25g

3-(1,3-benzothiazol-2-yl)-3-methoxypropanoic acid, 95.0%, 500mg

Methyl 2-(4-(4-hydroxyphenyl)cyclohexyl)acetate, 98%, 1g

2-Bromo-5-phenylthiazole, 95.0%, 250mg